Spots Global Cancer Trial Database for utuc
Every month we try and update this database with for utuc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study | NCT02793128 | Carcinoma, Tran... Transitional Ce... | UGN-101 instill... | 18 Years - | UroGen Pharma Ltd. | |
| uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto | NCT05874921 | Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Canc... Urothelial Carc... Carcinoma, Tran... Transitional Ce... | Jelmyto (mitomy... | 18 Years - | UroGen Pharma Ltd. | |
| Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma | NCT01606345 | Urothelial Carc... | Valrubicin | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study | NCT04620239 | Transitional Ce... | padeliporfin VT... | 18 Years - | Steba Biotech S.A. | |
| Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL) | NCT04574960 | Bladder Cancer Bladder Urothel... | Gemcitabine Cisplatin Carboplatin | 18 Years - | University Health Network, Toronto | |
| Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations | NCT04197986 | Upper Tract Uro... Urothelial Blad... | Infigratinib Placebo | 18 Years - | QED Therapeutics, Inc. | |
| Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC) | NCT05837806 | Neoadjuvant Imm... | tislelizumab+di... | 18 Years - | Tianjin Medical University Second Hospital | |
| A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma | NCT05779592 | Muscle-invasive... | 18 Years - | Bristol-Myers Squibb | ||
| Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations | NCT04197986 | Upper Tract Uro... Urothelial Blad... | Infigratinib Placebo | 18 Years - | QED Therapeutics, Inc. | |
| The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study | NCT02793128 | Carcinoma, Tran... Transitional Ce... | UGN-101 instill... | 18 Years - | UroGen Pharma Ltd. | |
| ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study | NCT04620239 | Transitional Ce... | padeliporfin VT... | 18 Years - | Steba Biotech S.A. | |
| Efficacy and Safety of UGN-101 in Recurrent Patients | NCT04006691 | Carcinoma Transitional Ce... Transitional Ce... | UGN-101 instill... | 18 Years - | UroGen Pharma Ltd. | |
| UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis. | NCT05043662 | Urothelial Carc... Diagnoses Disea... Ureter Cancer IMAGE Cytology | UroCAD assay, C... | 18 Years - | Changhai Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
